Laysbeauty

Laysbeauty is a synthetic biology company based in Beijing, China, dedicated to the research, development, and industrialization of recombinant humanized collagen. Utilizing a proprietary high-efficiency expression platform, the company produces collagen sequences that are 100% homologous to human collagen, ensuring high biocompatibility and low immunogenicity for medical and cosmetic use. Laysbeauty targets the medical aesthetics and regenerative medicine markets, offering products such as medical-grade skin repair dressings and raw materials for anti-aging treatments. The company is positioned as a leader in the synthetic biology and medical beauty sector, supported by significant venture capital investment from firms like IDG Capital and Hillhouse Capital. Their technology platform enables the production of various collagen types, including Type I and Type III, tailored for specific tissue repair and aesthetic applications.